Tumor cell migration in complex microenvironments by Polacheck, William Joseph et al.
Tumor cell migration in complex microenvironments
William J. Polacheck1, Ioannis K. Zervantonakis1, and Roger D. Kamm1,2,*
1Department of Mechanical Engineering, M.I.T., Cambridge, MA 02139
2Department of Biological Engineering, M.I.T., Cambridge, MA 02139
Abstract
Tumor cell migration is essential for invasion and dissemination from primary solid tumors and
for the establishment of lethal secondary metastases at distant organs. In vivo and in vitro models
enabled identification of different factors in the tumor microenvironment that regulate tumor
progression and metastasis. However, the mechanisms by which tumor cells integrate these
chemical and mechanical signals from multiple sources to navigate the complex
microenvironment remain poorly understood. In this review, we discuss the factors that influence
tumor cell migration with a focus on the migration of transformed carcinoma cells. We provide an
overview of the experimental and computational methods that allow the investigation of tumor cell
migration, and we highlight the benefits and shortcomings of the various assays. We emphasize
that the chemical and mechanical stimulus paradigms are not independent and that crosstalk
between them motivates the development of new assays capable of applying multiple,
simultaneous stimuli and imaging the cellular migratory response in real-time. These next-
generation assays will more closely mimic the in vivo microenvironment to provide new insights
into tumor progression, inform techniques to control tumor cell migration, and render cancer more
treatable.
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Introduction
The metastatic cascade is a complex, multistage process involving modulation of cell
phenotype, cell migration, and dynamic homeotypic and heterotypic cell-cell interactions
[1]. There are various proposed models for carcinoma progression and the formation of
metastases (reviewed: [2]), and tumors likely employ multiple mechanisms in vivo.
Metastatic carcinoma progression follows the general pattern of primary tumor growth,
tumor cell invasion, intravasation, circulation, extravasation, and growth of the secondary
tumor. However, the heterogeneous tumor microenvironment [3], plasticity of invasion [4],
and hypoxia-induced genomic instability [5] are among many factors that contribute to
tumor heterogeneity, and there is debate as to the source and onset of the metastatic
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phenotype [6], [7]. Most cancer-related deaths result from the formation of metastases [8],
which are difficult to detect and can remain dormant for years after treatment of the primary
tumor [9, 10]. The formation of these metastases by disseminated tumor cells is preceded by
and requires tumor cell invasion at the primary tumor site, a ubiquitous step in early tumor
progression that represents a viable target for therapy [11].
Disseminating carcinoma cells navigate through the tumor microenvironment, across the
basement membrane and into the surrounding stroma. Migration is a highly orchestrated
process in which cells are guided both by internal and external signals. Mechanical signals,
sensed by integrins [12] and other adhesion receptors [13], and chemical signals, sensed by
chemokine and growth factor receptors [14], influence the migration of tumor cells. Hence,
understanding the mechanisms that guide cell migration in response to various stimuli in the
tumor and stromal microenvironments is key to developing therapies that prevent tumor cell
migration and render cancer more treatable.
Because it is difficult to isolate the effects of an individual stimulus on cell migration in
vivo, in vitro models have emerged as powerful tools for investigating tumor cell migration.
These reductionist in vitro assays isolate a subset of stimuli that can be examined in detail to
enhance our overall understanding of the important chemical and mechanical signals that
guide tumor cell migration. A key assumption in many reductionist experiments is that
chemical and mechanical stimuli act in parallel. However, the migrating cell acts as a signal
integrator, sensing simultaneous stimuli, activating intracellular pathways, and responding
through organized processes that culminate in the extension of protrusions and subsequent
migration. Furthermore, tumor cells invade stromal tissue through a variety of mechanisms,
and the process of migration is dynamic and a function of tissue substrate [4]. As we look to
develop the next generation of assays for tumor cell migration, it is important to consider the
crosstalk between chemical and mechanical stimuli, and the role it plays in guiding the
migration of tumor cells.
We start by summarizing the experimental and computational approaches that have been
developed to study tumor cell migration, and highlight their benefits and shortcomings. We
then discuss the results of these studies and introduce the various stimuli that guide tumor
cell migration. We focus on single migrating tumor cells and we broadly divide the stimuli
into mechanical and chemical cues. We conclude by highlighting recent data demonstrating
that chemical and mechanical stimuli are not independent and the crosstalk among them
strongly influences cell migration. In conjunction with computational models, assays that
allow the application of several, simultaneous stimuli will provide insight into tumor cell
migration in vivo and help in the development of new methods to control and limit cell
migration, improving the efficacy of cancer therapy.
Experimental Methods to Study Tumor Cell Migration
The tumor microenvironment is comprised of a dynamic network of extracellular matrix
(ECM) proteins [15] bathed in interstitial fluid and a host of associated cells including
fibroblasts, bone marrow-derived cells, endothelial cells, and infiltrating immune cells
(reviewed: [16]). These stromal cells remodel the ECM and provide mechanical and
chemical signals to the tumor cells. The many components and the dynamic nature of the
tumor microenvironment (Figure 1) contribute to its complexity, but investigation of the
effect of individual stimuli on migration requires an environment in which the mechanical
and chemical properties can be tuned precisely with reproducibility. The requirement for
such control has led to the development of in vitro assays that mimic aspects of the in vivo
tissue. In vitro studies are well suited for dissecting the signaling pathways that govern cell
migration in response to a particular factor of interest, while in vivo studies can be utilized
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to investigate the relevance of these signaling pathways in the intrinsic tumor
microenvironment during different steps of the metastatic cascade. Different experimental
methods to assay tumor cell migration in vitro are presented schematically in Figure 2 and
summarized in Table 1 with their key advantages/limitations, parameters that can be
manipulated, and practical information for implementation.
Traditional in vitro assays
Single cell migration in response to soluble biochemical factors has been traditionally
assayed using Boyden chambers [17], or modifications of the original design (e.g. Zigmond
[18] and Dunn [19] chambers). Boyden chambers, also known as transwell systems,
incorporate a stiff, porous membrane between two cell culture chambers. Soluble factor
gradients can be established across the membrane, and the number of tumor cells that
migrate through the membrane, from one chamber to the other, is used as a metric for
migration (Figure 2). To improve upon the traditional transwell assay design, a hydrogel,
often Matrigel or collagen type I, can be placed on top of the membrane to study invasion
through a 3D matrix [17]. An alternative method to investigate cell migration in response to
localized chemokine gradients is the micropipette assay [20, 21], where a micromanipulator-
controlled micropipette is used to dispense predefined chemokine solutions in close
proximity to cells on a 2D substrate. However, chemokine gradients generated by
micropipette are transient and difficult to quantify.
Collective cell migration can be assayed by using a cell scraper [22] or a micropipette [23]
to generate a “wound,” or an area without cells in a cellular monolayer. Cell motility is
assayed by monitoring the time required for the “wound” area to be covered by the
collectively migrating cells. Alternatively, cell damage can be avoided by positioning a
barrier to migration, allowing cells to migrate in the area covered by the barrier upon its
removal [24]. These assays are known as “wound healing assays” and are typically limited
to two-dimensional substrates with uniform stimulation conditions, although stimulus
gradients can be created through modified assays involving microfabrication [25]. An
important advantage of these assays is the ability to perform live cell imaging and conduct
multiple parallel assays, enabling high throughput data generation [26].
Microfluidic in vitro assays
The limitations of conventional assays to precisely control microenvironmental stimuli have
led to the development of novel migration assays using microfabrication technology and 3D
ECM matrices. In particular, the ability to accurately position fluid streams in microfluidic
channels has enabled the development of microfluidic would-healing assays [27], and multi-
channel systems that allow the seeding of multiple cell types in 2D or 3D [28]. Other
approaches utilize microcontact printing methods to create patterned substrate-bound
gradients [29]. These novel assays enable the creation of user-defined microenvironments,
where the magnitude, direction, and temporal characteristics of biochemical and biophysical
stimuli can be precisely controlled.
Recent advances in microfluidic technology have made it possible to create novel assays that
allow precise control of the cellular microenvironment [30]. Microfluidic assays can also be
readily adapted for live cell imaging to reveal tumor cell migration dynamics, in response to
critical factors in the tumor microenvironment, such as chemokine gradients [31], interstitial
flow [32], electrical fields [33] and paracrine and juxtracrine interactions with other cell
types [34, 35]. Cell seeding in microfluidic platforms is performed by loading cells
suspended in fluid or hydrogel solution, and cell motility is monitored after establishment of
chemokine gradient or flow conditions. Microfluidic platforms enable the accurate control
of these microenvrinomental factors, allowing the establishment of well-defined
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combinatorial conditions to dissect the interplay of mechanical and chemical signals. Small
sample volumes and low cell numbers in microfluidic assays pose challenges for traditional
biochemical assays, and often data analysis in microfluidic migration assays is performed
using live cell imaging and immunofluorescence staining for proteins of interest.
Macroscale models
Mesenchymal cells in their intrinsic environment interact with a 3D ECM, characterized by
physical parameters including pore size and stiffness [36] and chemical parameters
including adhesion site density and bound ligand concentration. The development of novel
biomaterials has enabled the creation of 3D environments that provide control of both the
chemical and physical parameters of the ECM to study the effects of these factors on cell
migration [37]. Hydrogel matrices, such as collagen type I, Matrigel and synthetic matrices
have been used to investigate how ECM physical properties (e.g stiffness [38]), and tumor
cell proteolytic activity [39] influences tumor cell invasion. In these assays, tumor cells are
uniformly seeded inside a homogeneous 3D ECM and their migration characteristics are
monitored in real-time or after a given time period [39]. These are termed “macroscale
migration assays” because of the inability to control biochemical and biophysical factors at
the single cell level compared to microfluidic- or micropatterned-based assays. Elegant
methods have also been developed to investigate the effects of stiffness gradients (durotaxis)
on cell migration [40].
Micropatterned models
Integration of microfabrication technology with ECM patterning has enabled the creation of
1D, 2D or 3D micropatterned substrates to selectively define the topography for culturing
single or multiple cell types under well-defined cell positioning [41]. Micropatterned
substrates can be fabricated using different techniques, such as microstencil stamping [42] or
optical patterning [43]. Cell seeding in micropatterned assays is achieved in a similar way as
microfluidic platforms, where cells are positioned in different areas of the device by
pipetting cell suspensions. Interestingly, advanced micropatterning methods have also been
developed that allow for active control of the substrates and impose tunable constraints on
cell migration [44]. Doyle et al. developed an assay to investigate tumor cell migration along
1-D paths [43] and Irimia et al. studied the effect of physical geometrical constraints on
tumor cell migration persistence [45]. These technologies can recreate a more
physiologically relevant tumor microenvironment, including multiple cell types [46],
mimicking tumor cell migration along fibers in the tumor stroma and invasion in 3D [47].
Although these micropatterned assays offer scalability and the capability to culture large cell
numbers, they do not typically include fluid flow, and hence the application of chemical
gradients and localized mechanical (e.g. fluid shear stress) stimuli to cell subpopulations is
generally not possible.
Tumor cell migration assays in vivo
Intravital imaging of live animals at sufficient resolution to identify individual tumor cells
has allowed monitoring tumor cell migration in the native tumor microenvironment in vivo
[48, 49]. In these studies, human tumor cells are transplanted into different model organisms
such as mouse [50], zebrafish [51] and chicken embryo [52], or alternatively genetically
engineered mouse tumor models incorporating constitutively expressed fluorophores [53,
54] are employed. Intravital studies using multiphoton microscopy enable deep imaging
(~mm) into the tissue and also allow for second harmonic imaging to visualize ECM fibers
[53]. Wyckoff et al. have developed an in vivo chemotaxis migration assay to be used in
combination with monitoring tumor cell motility [55], which allows for the collection of the
tumor cells as they migrate inside a cytokine-filled needle.
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Computational Modeling of Tumors
Computational methods have been developed to augment experiments and gain deeper
insight into tumor development. Cancer progression has been modeled with a variety of
approaches (Figure 3), ranging in length scale from microscopic and discrete models that
consider individual cells, to macroscopic models that treat the tumor mass as a continuum
(reviewed: [56]). Such computational models provide insight into biological processes and
guide experimental development. For example, Baxter and Jain demonstrated that interstitial
flow velocity varies significantly for constant interstitial fluid pressure when the ratio of
transvascular to interstitial resistance is varied [57]. Interstitial fluid pressure can be
measured experimentally, while flow velocity is more difficult to assay. However, flow is a
strong regulator of drug delivery, so these computational models provide insight into the
barriers to drug delivery and inform more effective cancer treatment [58]. Although these
models have provided valuable insight into solid tumor progression, the treatment of a tumor
as a continuum does not allow explicit consideration of single cell behavior or the effectors
that regulate the behavior of individual tumor cells.
To improve on continuum models, Jeon et al. developed a hybrid discrete-continuum model
that implemented a continuum sub-model for chemical transport within the tumor and a
discrete sub-model for individual cell behavior such as cell adhesion strength (Figure 3D)
[59]. Because the hybrid model explicitly considers cell-cell adhesion sites, the model
produced realistic tumor morphologies that could not be generated by previous continuum
models. Several studies have also implemented a force-based, microscale approach to
effectively model the biphasic haptotactic and haptokinetic migratory response for tumor
cells in 3D matrices, and these models have provided insight into the parameter space of
adhesion and ECM stiffness that governs 3D migration speed [60], [61]. Although these
models establish a framework for studying cell migration through 3D matrices, they are
limited by certain assumptions such as fixed values for matrix density and cell adhesivity to
the matrix. Furthermore, the model described by Zaman et al. lacked consideration of
soluble ligand fields and thus could not account for chemotaxis. Anderson et al. developed
an agent-based model that predicts clonal evolution of a tumor as a function of the
microenvironment properties [62]. Such agent-based models have the advantages of
simulating multiple interacting cells, but require the input of numerous parameters or
assumptions, not all of which can be precisely or independently determined.
Subcellular models provide insight into mechanical and cellular processes that are difficult
to measure experimentally. The subcellular element model successfully captures cell-level
mechanical properties of cells by modeling the cell as a subset of nodes whose interaction is
governed by mechanical potentials between the nodes (Figure 3B) [63]; however, this model
lacks chemical reaction kinetics and cannot capture signal transduction. On the other hand,
chemical reaction models provide insight into signal transduction and have long been used
to predict the effect of a drug on cell function (Figure 3A) [64], but these models lack the
mechanical consideration to adequately capture cell migration.
Cell migration is inherently a multi-scale process, involving both mechanical and chemical
signal integration, and coarse-graining provides a technique for modeling multi-scale
phenomena. Contact guidance in migrating cell populations has been effectively modeled by
treating the cells as a continuum, where the continuum properties are derived from single
cell migration models [65]. To further improve this multi-scale approach, Ramis-Conde et
al. developed a hybrid discrete-continuum model and explicitly considered cell signaling in
the discretely modeled cells (Figure 3C). The signaling model allowed dynamic modulation
of cell-cell adhesion properties, which allowed simulation of intravasation [66]. However,
by considering signaling on a whole-cell level, the authors could not capture localized
Polacheck et al. Page 5













signaling events or simulate the effects of signaling gradients, which are critical in
carcinogenesis and metastasis formation. Parameter estimation and assumption validation
for computational models remains an issue for maintaining the physiologic relevance of the
models (a list of parameters relevant to tumor cell migration is provided in Table 2), but
advanced experimental platforms such as microfluidics provide resolution over parameters
that are difficult to estimate with traditional assays. For example, Irimia et al. recently
coupled their computational model for neutrophil chemotaxis to experiments performed in a
microfluidic device to aid in parameter estimation and model verification [67]. Thus, while
the potential for using computational models to gain insight into the complex and interactive
mechanisms that regulate tumor cell migration, there remains room for new approaches that
simultaneously encompass both chemical and mechanical stimuli, and are capable of
bridging scales from molecular to cellular to tissue.
Mesenchymal Migration
The experimental platforms and computational methods discussed above have provided
much insight into the mechanisms by which tumor cells migrate in the surrounding stroma.
In epithelial tissues, cells are tightly connected to their neighbors and form polarized cell
sheets with high levels of E-cadherin expression. During the formation of metastatic lesions
in carcinomas, epithelial cells undergo genetic and epigenetic changes that induce a
phenotypic transition, in which cells lose E-cadherin expression [68], reducing homophilic
cell-cell connections, and express vimentin [69], N-cadherin [70], and other fibroblastic
markers (Reviewed: [71]). This phenotypic switch is known as the epithelial to
mesenchymal transition (EMT), and results in cells of epithelial origin acquiring a
phenotype more amenable to migration and invasion into the surrounding tissue. The
migratory phenotype is varied and dynamic, with invading cells migrating individually or
collectively and modulating the mechanism of migration with changes in the stromal
properties (review of migration mechanisms: [4]).
Mesenchymal cell migration is an orchestrated process, requiring ECM remodeling,
extension of protrusions through actin polymerization, formation of new adhesions,
molecular motor-mediated cell contraction, and the release of adhesions at the trailing edge
(Reviewed: [72], [73]). Migration through 3D matrices is termed invasion, and tumor cell
invasion is mediated by invadopodia, specialized Src-kinase-dependent protrusions that are
selectively observed in metastatic cells and extend into the ECM to probe the proximal
chemical and mechanical microenvironment [74]. In general, cell migration is a stochastic
process [75], and in the absence of an external gradient or directional cue, cells migrate
randomly [76]. However, when presented with a directional cue, such as a chemokine
gradient, the internal signaling machinery becomes polarized and cells migrate with
directional bias [77]. Several metrics are commonly used to quantify aspects of cell
migration beyond speed and direction. Detailed persistence metrics such as root-mean-
squared speed, directional persistence time, and a random motility coefficient can be
determined by fitting experimental mean-squared displacement data with a theoretical
expression that models cell migration as a biased random walk [78]. Directionality, defined
as the ratio of net migration distance to the total distance traveled for a given period of time,
is a commonly used metric that is more straightforward to compute [79].
The stochasticity of cell migration and the fact that direction and speed can be modulated
independently complicates the use of end-point migration assays. For example, migration
with high speed and low persistence cannot be distinguished from low speed, highly
persistent migration. This issue is compounded in transwell assays, where only the number
of cells reaching and crossing the membrane is measured, and increased migration speed
with random direction could be confused with directionally biased migration. Furthermore,
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there is often significant cell-cell heterogeneity in cell migration characteristics, and
migration statistics are often averaged over a cell population. These bulk, or population-
averaged metrics can obscure aspects of the migratory response that may be important for
understanding the response of tumor cells to various stimuli. These disadvantages can be
overcome by the use of live-cell imaging in microfluidic systems. For example Haessler et
al. used population histograms and scatter plots to identify subpopulations of cells that
respond uniquely to interstitial flow, with downstream migrating cells moving with high
directional persistence and upstream migrating cells moving faster but with less directional
persistence, supporting the hypothesis that flow imparts simultaneous and competing stimuli
to tumor cells [80] [32].
Mechanical Signals
ECM stiffness and density
Traditionally, extracellular stimuli to migration are divided into mechanical and chemical
signals, and the ECM imparts a variety of mechanical signals to migrating cells. The
relationship between the density and organization of stromal tissue and tumor progression is
bilateral and dynamic, with tumor cell phenotype dictated by the stromal properties and
tumor cells modifying the chemical and mechanical profile of the stroma [81]. In particular,
the density and stiffness of the stromal ECM has been shown to influence the invasion of
tumor cells. Mammographically dense breast tissue has long been known to be a risk factor
for breast cancer [82], but recently, it was demonstrated that increased matrix density can
promote invasion of tumor cells even in the absence of stromal cells [83]. Collagen
crosslinking [84] and lysyl oxidase (LOX) over-expression [85] contribute to increased
ECM stiffness in the tumor stroma [38], and stiffness of the ECM is a critical regulator of
mammary gland function and morphology [86]. The surrounding stromal tissue in a normal
mammary gland is characterized by an elastic modulus of ~200 Pa, while the elastic
modulus of mammary tumor-associated stroma is ~4kPa (Table 2) [12].
The stiffness and density of the substrate are sensed by the cell through adhesion molecules,
primarily integrins [87], a class of tension-sensitive transmembane molecules that can
initiate the formation of a continuous mechanical link between the ECM fibers and cellular
cytoskeleton [88]. Integrins are both substrate and tension dependent [89], and activation
and clustering of integrins initiates a mechanosensitive signaling cascade [90]. The
mechanical strength of cell-ECM adhesions is dependent on integrin engagement [91].
Vinculin recruitment, a measure of matrix adhesion maturation and an integrin signaling
component, is dependent both on externally applied force [92], and internally generated
myosin-mediated force [93]. Integrins are overexpressed in cancer cells, and a drug that
blocks αVβ3-integrins has been shown to increase apoptosis and the efficacy of radiation
treatment of mice with mammary adenocarcinoma [94].
Advances in techniques to engineer substrate stiffness in vitro have allowed investigation of
the effect of ECM stiffness on tumor cells. Similar to the mechanosensing by fibroblasts and
other cell types [95], prostate tumor cells are sensitive to substrate stiffness, increasing their
elastic modulus with an increase in the substrate stiffness [96]. Interestingly, breast cancer
cells that overexpress the receptor tyrosine kinase ErbB2 are more sensitive to substrate
stiffness [97]. Furthermore, ECM stiffening contributes to altered integrin and ERK
signaling, resulting in high Rho-dependent cellular contractile stress, disrupting the breast
epithelial phenotype and promoting the malignant phenotype [12].
Rho-mediated contractile stress and integrin signaling are key regulators of cell migration
[98], and integrin signaling is altered in tumors (Review of integrins in cancer: [99]).
Recently, a technique involving crosslinking collagen in vitro enabled Levental et al. to
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demonstrate that the increased stiffness of tumor-associated stroma increases levels of β1
integrin and FAKpY397 colocalization, and that these signals contribute to increased breast
tumor cell invasion through enhanced PI3K signaling [38]. The rigidity of the substrate
alters invadopodia function of breast cancer cells, with enhanced matrix degradation and
more functional invadopodia per cell on stiffer substrates [100].
Cellular contractile stress generation is required for rigidity sensing [13], and interfering
with myosin motor activity attenuates the effects of stiffness on migration. Myosin light
chain kinase inhibitor ML-7 impedes invadopodia maturation and decreases FAKpY397 and
CaspY165 localization within breast carcinoma invadopodia [100], and inhibition of myosin
II or Rho-associated kinase (ROCK) attenuates the ability of glioma cells to sense substrate
rigidity [101]. Stiffness sensing is also cell-type specific, and the stiffness-dependent
invasion of breast cancer cells into 3D matrices is dictated by the specific genetic profile of
the metastatic cells. Single cell subpopulations of MDA-MB-231 have been shown to
demonstrate tissue-specific metastatic lesions, tissue tropisms [102], and these
subpopulations have shown varying stiffness-dependence when invading 3D tissues. For
example, breast cancer cells that metastasize to bone do not show stiffness dependent
invasiveness; however, cells that metastasize to the lung invade less with increasing stiffness
[103].
Although most experiments to date investigate cell migration as a function of stiffness on
substrates or within matrices of uniform stiffness, stiffness gradients can guide cell
migration on 2D substrates [40], and in 3D [104], [105]. Furthermore, patterning stiffness on
substrates has been shown to lead to self-aggregation of fibroblasts [106]. The tumor
microenviornment is heterogeneous, characterized by abrupt changes in the mechanical
properties of the tissue [107], and the role this mechanical heterogeneity plays in guiding
cell migration has yet to be determined. However, improved resolution in measuring the
mechanical properties of tumors in vivo, multi-scale models that address substrate and cell
mechanics, and improved techniques for creating artificial ECMs with customized
mechanical properties will provide insight into the relationship between stiffness gradients
and cell migration.
MMPs and matrix synthesis
As mentioned above, stiffness and stiffness gradients have been shown to influence cell
migration on 2D substrates, and recently, there has been much interest in determining the
role of stiffness of 3D matrices on cell invasion. In 2D, mechanical properties can be easily
quantified using a variety of rheometrie techniques, and these bulk mechanical properties
agree well with microscale mechanical properties measured with techniques such as atomic
force microscopy (Review of 2D vs. 3D for cancer cell invasion: [36]). However, 3D
matrices that mimic in vivo ECM are fibrous and the material is structured on cellular length
scales, so assessing the mechanical properties relevant to cell migration is challenging. For
example, the storage modulus of a 0.5 mg/ml collagen hydrogel is less than 10 Pa [108],
while the extensional modulus of a fiber is on the order of GPa [109]. The coupling of
matrix ligand density, pore size, and matrix stiffness in 3D migration assays employing
collagen type I hydrogels further complicates investigation of the role of mechanical
properties on 3D tumor cell invasion. For example, increasing hydrogel matrix protein
density increases stiffness but also decreases pore size and increases ligand density. Tumor
cell invasion is regulated both by pore size and stiffness [110] and crosslinking techniques
provide orthogonal control of matrix ligand density and stiffness, though pore size and
stiffness remain inversely coupled [108].
Cells in matrices with subcellular pore sizes implement a combination of force and
proetolytic matrix degradation to overcome the structural barrier to migration imposed by
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the matrix fibers. Transformed breast carcinoma and fibrosarcoma cells apply force to
collagen fibers to reorganize and reorient local matrix, while MMPs focally degrade matrix
to reduce steric hindrance [111]. MMPs are key regulators of carcinogenesis, and their
function extends beyond degrading matrix proteins [112]. As tumor cells secrete MMPs to
degrade the interstitial matrix, this provides microtracks of weakened and digested matrix
enabling migration of subsequent cells [113]. MMPs diffuse from tumor or stromal cells into
the surrounding interstitium [112], and the expression, secretion, and action of MMPs
couples the tumor cell chemical and mechanical microenvironment. For example, MT1-
MMP expression is required for carcinoma cells to digest matrix proteins and invade into 3D
matrix [114], and MT1-MMP activity is also required to activate surface-bound TGF-β in
carcinoma cells, which affects cell growth and matrix secretion [115]. Furthermore, MMP
cleavage of matrix materials can release soluble cytokines that are bound to the ECM in
inactive, precursor form [116], and the transport environment within the tissue can induce
gradients in these soluble signals, providing directional cytokine cues to cells [117].
Intercellular mechanical signals
Fibroblasts are stromal cells that remodel the ECM through secretion of type I, type II, and
type V collagen and fibronectin and contribute to basement membrane formation through
secretion of collagen type IV and laminin (Review of fibroblasts in ECM remodeling:
[118]). In tumors, stromal fibroblasts acquire an activated phenotype similar to fibroblast
activation in wound healing [119], with 80% of stromal fibroblasts achieving the activated
phenotype in breast carcinomas [120]. Along with myofibroblasts [121], these cancer
associated fibroblasts (CAFs) are characterized by increased deposition of matrix, known as
desmoplasia, which contributes to the increased stiffness of tumor-associated ECM (Review
of CAFs: [122]), and CAFs demonstrate altered gene expression from normal stromal
fibroblasts including upregulation of genes governing ECM deposition [123]. CAFs
dynamically interact with tumor cells, sensing changes to the matrix through integrin-
dependent adhesions, and further regulating the ECM by modulating matrix and MMP
secretion. The dynamic evolution of the tumor stroma is known as stromagenesis (Review of
stromagenesis: [124]), and altered stroma is a key feature of carcinogenesis [125].
CAFs alter the mechanical landscape of the tumor stroma and contribute to increased
invasiveness of carcinoma cells [126]. In addition to the desmoplasia-associated matrix
stiffening, fibroblasts generate high levels of contractile stress and can thus apply tensile
stresses to the surrounding ECM. Fibroblasts seeded in 3D collagen gels increase the
mechanical stiffness and resistance to fracture of tissue constructs [127], and TGFβ-
activated fibroblasts seeded in 3D collagen gels can induce Rho-dependent contraction of
these constructs [128]. These CAF-mediated alterations to the mechanical properties of the
tumor stroma promote the invasive phenotype, and fibroblasts can directly promote the
invasion of carcinoma cells. Migrating fibroblasts locally degrade matrix and secrete
fibronectin and tenascin-C when seeded in collagen type-I and Matrigel hybrid tissue
constructs. The matrix degradation is dependent on integrin engagement and Rho- and
ROCK-mediated regulation of myosin light chain activity, suggesting that cellular tension
generated by the fibroblasts is necessary to degrade the matrix. These microtracks, created
through matrix degradation, are sufficient to promote carcinoma cell migration, even when
Rho and ROCK are blocked in the migrating tumor cells; however, the tumor cell migration
requires Cdc42 and MRCK to modulate myosin light chain accumulation and activity [129].
The effects of the microtracks on tumor cell migration suggest fibroblast-mediated local
mechanical and matrix architectural stimuli guide tumor cell migration, and advances in
micropatterning technology and computational models for investigating pericellular matrix
organization [130] will provide further insight into the mechanisms by which fibroblasts
influence migration of local tumor cells.
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Bulk reorganization of the tumor ECM during cancer progression promotes cell invasion,
and mammary tumor explants cultured ex vivo within collagen hydrogels reorganize the
peripheral collagen fibers [131]. In mouse models, mammary tumor stroma is characterized
by structured, dense collagen type I. The collagen fibers are strained around the tumor and
oriented normal to the tumor surface at the tumor margin. The aligned collagen fibers
correlate with local cell invasion, and both collective and single cell invasion are observed
along the radially oriented collagen fibers [131], consistent with the observation that
metastatic carcinoma cells migrate in the direction of collagen fibers in vivo [132].
Questions remain, however, regarding the mechanism by which the ECM is altered in tumor
development. For example, it remains to be seen whether dense collagen regions promote
carcinogenesis and precede tumor growth or whether collagen alignment is induced by
increased matrix contraction by the epithelial tumor cells and altered matrix deposition by
activated fibroblasts during tumor growth. Furthermore, questions remain as to whether the
radial collagen fibers are formed by invading cells at the tumor periphery or if the aligned
fibers precede and promote cell invasion.
Just as fibroblasts can reorganize the stromal matrix, tumor cells can induce topographical
stimuli that guide migration. ROCK-mediated epithelial cell contractility can locally deform
the ECM, even in the absence of protease activity and stromal fibroblasts [133], and in vitro,
Rho/ROCK and myosin-dependent contractility of carcinoma cells can lead to alignment of
collagen fibers normal to the tumor periphery [134]. Alignment of collagen fibers has long
been known to influence fibroblast migration through increased migration velocity along the
fibers and suppressed migration normal to the fiber alignment direction, a mechanism
known as contact guidance [135], and fibroblasts migrate rapidly along micropatterend lines
of matrix [43]. Interestingly, fiber alignment promotes carcinoma cell invasion in the
direction of the fibers even when Rho and ROCK activity is blocked in the migrating cells,
suggesting that tension generated in the stroma could promote invasion through collagen
fiber alignment [134]. These results, in conjunction with the data mentioned above from
Gaggioli et al. on fibroblast-generated microtracks, suggest that restriction of cell-ECM
adhesions, either by fiber alignment or cell confinement, provides a strong directional
stimulus for tumor cell migration.
Recently, advances in experimental techniques have provided insight into the role of
mechanical confinement on cell migration. Irimia and Toner developed a microfluidic
platform to confine cells in channels of varying cross-sectional area, and they found that in
channels with cross-sectional dimensions comparable to a cell diameter, tumor cells,
including breast, lung, prostate, and colorectal adenocarcinoma, migrated rapidly with high
directional persistence [45]. These channels, however, were rigid and nonporous. Recently,
Ilina et al. implemented a two-photon laser ablation technique to generate microtracks
within collagen matrices and found that not only do the microtracks guide the migration of
breast cancer cells even in the absence of MMP activity, but the cells use an MMP-
independent pushing mechanism to expand the track diameter during migration [136]. One
limitation of these studies is that the channels were synthesized from uniform hydrogels,
whereas in vivo fibroblasts create microtracks and secrete matrix proteins, producing spatial
heterogeneity in the chemical and mechanical signals within the tissue. Advances in
micropatterning techniques could provide insight into how the altered chemical, mechanical,
and steric properties of the microtrack influence cell migration in vivo.
Solid stress
Growth of a tumor within a confined tissue compresses the surrounding matrix and
generates compressive stresses, which in combination with elevated interstitial fluid pressure
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[137], contributes to high levels of solid stress within the tumor [138]. To investigate the
role of the compressive stresses on tumor progression, Helmlinger et al. developed a
technique for growing tumor spheroids within agarose gels and demonstrated that solid
stress generated by the growing spheroid limited tumor growth [139]. Computational models
accurately captured the experimentally observed growth curves and verified that increasing
agarose density further limits growth by increasing the radial and circumferential stresses
generated by growing spheroids [140]. Subsequent work has demonstrated that compressive
stresses limit the growth of tumor spheroids by increasing apoptosis while decreasing
proliferation, with the spatial regions of highest compressive stress corresponding to the
highest rates of apoptosis [141]. High compressive stress within tumors, which can collapse
intratumoral blood vessels [142], can also influence the invasive properties of cells within
the tumor by creating hypoxia and high interstitial pressure. Compressive stress increased
the motility, measured by the rate of migration in a wound-healing assay, of transformed and
partially transformed breast carcinoma cells, while it suppressed the migration of non-
malignant breast epithelial cells. The increased level of invasion was dependent on the
development of leader cells [143], characterized by high directional persistence and
directionality in their migration, and myosin light chain kinase inhibitor ML-7 blocked the
migration of leader cells, suggesting a role for intracellular tension in the migration response
to compressive stress [144].
Chemical Signals
Chemotaxis
Traditionally, chemical migratory stimuli, mediated primarily by soluble chemical signals,
have been considered independently of mechanical stimuli. Gradients in soluble molecules
can guide the migration of tumor and stromal cells and modulate cancer progression [145].
Tumor cells and stromal cells sense the local concentration of chemokines and growth
factors through surface receptors, and a recent review highlights the key factors and
pathways involved in chemotaxis in cancer progression [14]. Chemokine receptors are often
up-regulated in cancer cells in vivo [146], and both tumor cells and stromal cells migrate in
response to chemokine gradients. Chemokines can be secreted autologously, released from
the matrix, or secreted by stromal cells, and cells respond to the magnitude of the
transcellular chemokine gradient as well as the mean chemokine concentration [147].
Despite the growing body of work on the molecular mechanisms behind directional sensing
and migration in cancer cells, little is known about the chemo-mechanical dynamics of
chemotaxis in 3D environments. Furthermore, tumor cells secrete chemokines, and autocrine
chemokine gradients can guide cell migration in the absence of an externally applied
chemokine gradient [148]. Tumor cells in vivo are likely exposed to multiple, competing
chemotactic stimuli, and it is unknown how tumor cells respond to simultaneous growth
factor gradients. As discussed below, there is crosstalk and cooperation between growth
factor receptors and integrins, and the mechanical environment must be considered when
evaluating tumor cell chemotaxis. The advent of new, microfluidic platforms for
investigating chemotaxis [149] will help to elucidate the mechanisms by which cells
integrate mechanical and chemical signals in vivo.
Heterotypic tumor-stromal cell paracrine signaling
Chemical signal gradients that regulate tumor cell chemotaxis can be established through
secretion of soluble chemokines by non-cancerous stromal cells and diffusion through the
ECM in the tumor microenvironment. This cell-cell communication through paracrine
factors is critical during tumor progression and invasion [150] and involves a variety of
different cell types in the tumor microenvironment, such as fibroblasts, immune and
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endothelial cells [151]. Recent progress in characterization of these cells showed that
stromal cells isolated from mammary tumors have altered gene expression patterns [152]
compared to their normal counterparts. These stromal cells have been characterized as
“cancer-associated stromal cells,” such as cancer-associated fibroblasts [122] and tumor-
associated macrophages [153]. The study of these interactions in vivo is difficult because of
the challenges with precisely dissecting the underlying molecular pathways. Traditionally
transwell assays have been employed to study the migration or invasion of tumor cells in
response to unidirectional conditioned medium or bi-directional signaling with stromal cells,
while in recent years a large number of investigators have also developed new
microsystems-based assays [28, 35, 46, 154]. Stromal-tumor cell interactions may also
include juxtracrine signaling involving direct physical contact [150] and through secretion
and binding of ECM molecules. Our focus here is on how tumor cell migration is regulated
through stromal cell secreted factors; however, an important direction for further
investigation is the mechanisms by which tumor cells modulate stromal cell phenotypes and
how these changes can subsequently result in feedback loops further promoting tumor cell
invasion.
Tumor-macrophage and tumor-fibroblast interactions
In vivo studies utilizing a microneedle chemotaxis invasion assay and multiphoton imaging
showed that carcinoma cells and macrophages interact via a paracrine loop involving colony
stimulator factor 1 (CSF-1) secreted by the tumor cells to signal EGF secretion by the
macrophages leading to tumor cell chemotaxis. Involvement of this paracrine loop in
promoting tumor cell invasion has also been demonstrated in vitro through studies of
macrophage-tumor cell signaling [155]. De Wever et al. demonstrated that myofibroblasts
isolated from cancer stroma, or TGF-β transformed fibroblasts induce proinvasive activity in
colon cancer cells through production of the extracellular matrix glycoprotein tenascin-C
and secretion of scatter factor/hepatocyte growth factor (HGF) [156]. In their study,
however, they did not address the question of whether physical contact between the two cell
types was required to establish the proinvasive effects on cancer cells. A microfluidic model
incorporating 3D co-culture of carcinoma cells and fibroblasts was utilized to demonstrate
that cancer cell invasion was upregulated by cancer-associated fibroblasts compared to their
normal counterparts [157]. Sung et al. developed a microfluidic 3D compartmentalized
system of co-cultured epithelial cells and fibroblasts to study the transition from a localized
carcinoma into an invasive carcinoma [154]. By modulating the intercellular distance
between the two cell types, the authors demonstrated that morphology of the mammary
clusters changes with direct contact between the two cell types, leading to a more invasive
phenotype with long protrusions.
Tumor-endothelial cell interactions
Using a transwell-based co-culture model of human glioblastoma and microvascular
endothelial cells Kenig et al. demonstrated that endothelial cells increased the invasiveness
of cancer cells. Enhanced tumor cell invasion was driven by endothelial cell SDF-1
expression resulting in increased expression of MMP-9 by the tumor cells [17]. Kaji et al.
used a micropatterned system to co-culture HeLa and HUVEC cells, which included fluid
flow control to direct transport of soluble factors from the tumor to the endothelial cells or
vice-versa. Interestingly, tumor conditioned medium resulted in retraction of the endothelial
monolayer, while endothelial conditioned medium did not influence the migration of HeLa
cells [46]. Recently, Franses et al. investigated the role of endothelial cells in tumor cell
proliferation and invasion, and the authors showed that dysfunctional endothelial cells,
which expressed lower levels of perlecan, secreted higher levels of interleukin-6 (IL-6),
resulting in increased invasion of human breast and lung carcinoma cell lines [158]. Apart
from blood vessel endothelial cells, lymphatic endothelial cells have also been implicated in
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cancer metastasis. Using a co-culture transwell assay, Issa et al. [159] demonstrated that
lymphatic endothelial cells promoted melanoma cell proteolytic activity and motility via a
paracrine loop involving tumor cell secreted VEGF-C and lymphatic endothelial cell
secreted CCL21.
Interactions of tumor cells with multiple stromal cell types
Although most studies have investigated the interaction between tumor cells and a single
stromal cell type, recent experiments employed three different cell types to mimic more
closely the tumor microenvironment. Interestingly different stromal cell types may also
communicate directly via paracrine signals and secrete factors that inhibit or promote tumor
cell migration factors. Hsu et al. employed a microfluidic model with three chambers to
demonstrate that macrophage-conditioned medium reduced the ability of myofibroblasts to
promote lung adenocarcinoma cell migration [34]. Walter-Yohrling et al. showed that tumor
cells of different origin, including breast, ovarian, prostate, and lung carcinoma, have
positive or negative effects on the induction of endothelial/myofibroblast invasion in a tri-
culture organotypic assay [160]. Clearly, multiple cell type interactions are implicated in
tumor cell invasion, and further studies are needed that incorporate a greater variety of
tissue-specific cells to better mimic the in vivo microenvironment.
Chemo-mechanical crosstalk
Interstitial flow
Interstitial fluid provides a transport medium for nutrients and signaling molecules [161,
162]. Jain and Baxter identified that elevated interstitial fluid pressure (IFP) within the
tumor interstitium inhibits drug delivery to tumor tissue [163], and subsequent work
established a mathematical framework for determining the critical parameters that govern
transport of soluble species from the vasculature into neoplastic tissue [57]. High blood
vessel permeability, elevated oncotic pressure [164], and abnormal lymphatic vessels
contribute to high IFP within the tumor, and high intratumoral pressure has been correlated
with poor prognosis in vivo [165]. IFP within tumors can be nearly as high as the
microvascular pressure (up to 30 mmHg [137]), while IFP in normal tissue is close to zero
[166], and this difference in pressure between normal and neoplastic tissue leads to high IFP
pressure gradients at the tumor margin. IFP gradients drive convection of interstitial fluid,
and Chary and Jain determined typical interstitial flow (IF) speeds to be on the order of 0.1–
2.0 µm/s [167]. The magnitude of IF velocity depends on the magnitude of the IFP gradient
and the hydraulic conductivity of the tumor (Table 2), and subsequent work has indicated
that the velocity can reach up to 4.0 µm/s [168]. Computational models demonstrate that IF
velocity is a function of the ratio of interstitial to vascular flow resistance [57], and when the
resistance to IF transport is much greater than resistance to vascular transport, IF velocity at
the tumor periphery can reach as high as 10.0 µm/s [166].
The convection of soluble signals by interstitial flow provides a host of migration signals to
invading tumor cells by transporting both autocrine and paracrine chemokines (Review of IF
and effects on tumor cell invasion: [169]). In recent work by Shields et al., IF was found to
increase the metastatic potential of breast cancer and melanoma tumor cells through binding
of self-secreted chemoattractant via the CCR7 receptor [170]. This autocrine signaling,
termed “autologous chemotaxis,” arises when IF transports secreted ligand downstream, and
the balance between convection and diffusion establishes a Peclet number-dependent
pericellular gradient, which provides a chemotactic signal in the downstream direction
[117]. IF also influences fibroblast function, promoting matrix reorganization,
differentiation into myofibroblast phenotype [171], and fibroblast migration [172], and these
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mechanisms prime the stromal environment through MMP secretion and Rho-dependent
matrix contraction to promote tumor cell invasion [173].
Computational models have helped elucidate the effects of IF on the mechanical
microenvironment, and the simulations demonstrate that IF applies stress to matrix fibers,
which can be sensed by the cell through matrix adhesions [174], and IF imparts shear stress
on the cell membrane, the magnitude of which is determined by the arrangement of matrix
fibers [175]. Recent work demonstrates that when the CCR7 receptors are blocked, breast
cancer cells migrate in the upstream direction, and the data suggest that the upstream
stimulus is mechanically-mediated. This flow mechanotaxis arises primarily from pressure
gradients across the cell resulting in a net force on the cell in the flow direction, which is
balanced by a net force on matrix adhesions in the upstream direction (Figure 4) [32].
Originally, flow mechanotaxis was thought to be mediated by tension in integrins, supported
by the increase FAKpY397 in cells exposed to flow, but recently a potential role for the
glycocalyx has been identified in the cellular response to interstitial flow. Interstitial flow
increases the migration of vascular smooth muscle cells through increased MMP13
expression, mediated by heparan sulfate proteoglycans [176]. Although this work was
performed with vascular smooth muscle cells, syndecan expression in breast cancer has been
demonstrated [177], though it remains to be seen whether proteoglycans play a role in the
tumor cell response to interstitial flow.
Although the details of the mechanism guiding cells to migrate upstream has yet to be
verified, recent evidence supports the hypothesis that IF imparts competing stimuli on
migrating breast cancer cells [80]. The flow-induced expression of MMPs in fibroblasts
[172], further complicates investigation of IF as a migration cue as the MMPs degrade the
matrix, altering the flow field and pressure distribution around the cell. In glioma cells, fluid
stress activates MMP1 [178], and secreted soluble MMPs could be convected downstream,
degrading matrix on the downstream side of the cell, further activating adhesion molecules
on the upstream side, though that remains to be demonstrated.
Focal adhesion kinase and Src kinase as mediators for crosstalk
IF applies chemical and mechanical stimuli to cells, but the signals are further coupled
intracellularly through shared signaling pathways from chemical and mechanical receptors
(Figure 4). Focal adhesion kinase (FAK) is an important regulator of tumor progression,
with elevated FAK expression found in invasive human cancers [179], and FAK has been
identified as a potential target for cancer therapeutics [180]. Autophosphorylation of FAK at
Y397 requires the cell to be bound to a rigid substrate, while clustering of integrins can
induce phosphorylation at other sites in FAK [181], and autophosphorylation at Y397
increases linearly with stiffness of the substrate [91]. FAKpY397 increases the affinity of
FAK for the Src homology 2 domain of many proteins, including Src kinase [182], which
can further phosphorylate FAK at other tyrosines, resulting in full activation of FAK
enzymatic activity [183].
FAK further regulates downstream signals crucial to cell migration, and FAKpY397 is
required for cell motility [184], [185]; however, the role of FAK in 2D cell migration and
3D invasion seems to be different. Expression of v-Src restores 2D migration defects in
FAK−/− fibroblasts, but FAK expression and the formation of a FAK-Src signaling complex
was required for 3D cell invasion [186]. The discrepancy between 2D and 3D is presumably
due to the fact that the FAK-Src-p130cas signaling construct leads to activation of MMP-2
and MMP-9 and matrix degradation for invasion [187]. Src further contributes to
mechanotransduction through selective modulation of integrin-dependent traction forces
[188].
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FAK and Src are also key regulators of chemokine-induced migration. FAK can be
transphosphorylated by activated EGFR, and FAK function is required for EGF-stimulated
chemotaxis and motility [184]. Src can also be directly phosphorylated by EGFR [187], and
as FAK is recruited to sites of integrin clustering and is required for growth factor-
stimulated motility, Src is likely involved in the cooperativity or crosstalk between growth
factor and integrin signaling [184]. The intracellular coupling of chemical and mechanical
stimuli through FAK/Src complicates cell migration assays because testing for
phosphorylation of FAK, Src, or downstream components does not distinguish between
chemical and mechanical activation. Thus, assays that allow independent modulation of
chemical and mechanical stimuli, or assays for further upstream signals, such as vinculin,
are required to test the mechanism of activation within the cell.
Growth factor and integrin crosstalk
Integrins regulate the activity and downstream signaling of receptor protein tyrosine kinases
(RPTKs) such as EGFR, coupling adhesion and growth factor signaling [189]. Matrix
adhesion induces the formation of integrin-EGFR macromolecular signaling complexes
[190], and integrin clustering can induce phosphorylation and activation of EGFR and
downstream signals (Review of integrin and growth factor cooperation: [191]). The
association of integrins and growth factor receptors introduces crosstalk between adhesion
and growth factor pathways, and this crosstalk necessitates consideration of the ECM when
investigating chemokines and vice versa (Figure 4). For example, when breast cells are
cultured in 3D, blocking of β1 integrin or EGFR reduces expression of both receptors,
restoring malignant breast cancer cells to the normal epithelial phenotype, an effect not seen
when the cells are cultured on 2D substrates [192]. Integrins can also act to amplify growth
factor signals influencing chemokine-induced invasion. In carcinoma cells α6β4 integrin
associates with and is phosphorylated by the HGF specific receptor tyrosine kinase c-Met,
and functional α6β4 integrin is required for HGF-dependent invasion [193]. The crosstalk
between integrins and growth factor receptors results in coupling between the chemical and
mechanical microenvironments, and recently it has been shown that stiffening of the ECM
can increase the sensitivity of epithelial cells to EGF [194].
This relationship between integrins and growth factor receptors is bi-directional, and growth
factor activation can influence integrin function. In prostate carcinoma cells, binding of the
chemokine CXCL12 to its receptor CXCR4 increases adhesion to the ECM through α5 and
β3 integrin activation [195]. Recent work demonstrated that α5β1 integrin binds to and
activates c-Met, which initiates Src/FAK signaling and promotes migration in ovarian
cancer cells. Blocking α5β1 integrin or c-Met decreases Src/FAK activation and cell
invasion in vitro and inhibits metastasis formation in vivo; however, activation of c-Met by
soluble HGF can restore the ovarian cancer invasive potential even when α5β1 integrin is
blocked. Importantly, the integrin-mediated activation of c-Met was substrate-specific, and
c-Met phosphorylation by integrin was not observed on collagen substrates [196].
Integrin and cadherin crosstalk
ECM adhesion-growth factor crosstalk is further complicated by crosstalk between cell-
ECM and cell-cell adhesion molecules. A variety of mechanisms contribute to matrix and
intercellular adhesion crosstalk (Review of adhesion crosstalk: [197]), including feedback in
which integrin activation alters cadherin expression and vice versa. The Src/FAK signaling
complex is at the heart of this crosstalk [198], and c-Src suppression in breast cancer cells
results in E-cadherin upregulation, reversion of the mesenchymal phenotype to an epithelial
phenotype, and reduced cell migration [199]. Using a dual-micropipette technique,
Martinez-Rico and colleagues demonstrated that the force required to separate cell doublets
attached by E-cadherin mediated adhesion was dependent on specific integrin engagement,
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and that cells, including carcinoma cells, attached to fibronectin-coated beads required a
larger force to separate cell doublets than cells attached to vitronectin- or polylysine-coated
beads [200]. Patterning of ECM ligands further allows the regulation of cell-cell junction
morphology and force distribution [201]. Recently, Borghi et al. implemented a reductionist
micropatterning technique to investigate crosstalk of cadherin- and integrin-mediated
adhesions in governing epithelial cell motility. The micropatterning technique allowed cells
to simultaneously adhere to collagen IV and the extracellular domain of E-cadherin.
Micropatterning directed traction force and migration parallel to the major axis of areas
printed with collagen IV. Notably, the presence of E-cadherin stripes decreased lamellipodia
activity but did not affect migration rate. Depletion of αE-catenin within the epithelial cells
increased lamellipodia activity, migration rate, and decreased migration coordination among
epithelial cell sheets [202]. These results suggest E-cadherin engagement influences the
direction of migration but not migration rate, consistent with the results of Abercrombie and
Haynes who originally postulated contact inhibition in fibroblasts [203]. Interestingly,
contact inhibition is lost in tumor cells [204], and recently, it has been shown that matrix
stiffening results in the loss of contact inhibition and acquisition of a malignant phenotype
[194].
Conclusions and Future directions
In this review, we provide an overview of recent experimental studies that investigate the
effects of different factors present in the tumor microenvironment on tumor cell migration.
These experimental approaches have provided great insight into the factors that guide cell
migration in vivo, but the experimental platforms often trade precision for physiologic
relevance. Computational models have been developed to supplement experimental data, but
cell migration is inherently a multi-scale process, and models developed thus far lack the
capability of simulating cancer progression and cell migration at various length scales.
Mechanical stimuli such as ECM topography, ECM stiffness, pore size, solid stress, and
matrix contraction, and chemical stimuli from autocrine and paracrine sources influence the
direction and speed of cell migration. These various signals signal simultaneously to the
tumor cells, and tumor cell migration is an integrated response to multiple signals. Despite
significant progress in unraveling the underlying molecular mechanisms and signaling
pathways for transducing individual stimuli, the crosstalk between these different factors in
the tumor microenvironment at the extracellular and intracellular levels remains largely
unknown.
Integrating computational and experimental approaches will allow for a more detailed
understanding of these mechanisms and their interplay, and this strategy has proven to be
successful regarding the treatment of pancreatic ductal adenocarcinoma. Computational
modeling has demonstrated that IFP acts as a barrier for drug delivery to tumors [57], and
these models suggest that altering vascular and interstitial permeability could increase the
efficacy of anti-tumor therapy [166]. In vitro experiments, coupled with in vivo data, have
further demonstrated that IFP and IF alter the migration properties of migrating tumor cells
and suggest that IF might increase the formation of metastases [170], [32]. Recently,
Provenzano et al. demonstrated that by enzymatically degrading matrix elements in the
tumor stroma, IFP is significantly reduced within the tumor allowing increased transport of
small molecule therapeutic drug, which resulted in increased mouse survival and decreased
formation of metastases [205]. Furthermore, a growing body of work, motivated in-part by
computational models, suggests that targeting the tumor microenvironment in combination
with anti-angiogenic therapy, increases drug transport and improves cancer therapy [58].
To this end, development of the next generation functional migration assays that enable
integration of spatiotemporal control of mechanical and chemical signals with high-
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resolution, real-time imaging and the ability to conduct biochemical assays is crucial. The
investigation of tumor cell migration at the single cell level will allow investigation of the
diverse migration strategies employed by individual tumor cells inside the complex and
heterogeneous tumor microenvironment. Progress in this direction will help to develop more
accurate diagnostic techniques to quantify and predict cell migration in patients, thus
informing methods for constraining tumor cell dissemination and halting metastasis
formation.
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A host of biochemical and biophysical factors influence the migration of tumor cells.
Mechanical signals include stiffness of the ECM, the pore size of the ECM, solid stress,
fiber alignment, and fibroblast generated matrix tension and microtracks. Fibroblasts are
activated to assume the cancer associated fibroblast (CAF) phenotype, and these cells
secrete altered matrix components and generate tension. Chemical signals include autocrine
gradients, MMPs, oxygen tension, and paracrine signals from the vasculature, lymphatics,
and stromal cells.
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Experimental methods for investigating factors that influence tumor cell migration In vitro
tumor cell migration assays (reviewed in Table 1). Micropipette assay [21]: a pipette is
placed in the vicinity of the cell and a chemoattractant solution is injected into the culture
medium establishing a growth-factor gradient. . Boyden [17] (or transwell) chamber : Cells
are seeded in suspension in the top chamber and migrate through the porous filter (black
rectangles) in response to a chemokine gradient, which is established by the different culture
medium concentrations in the top and bottom chambers. Micropatterning [29]: Cells are
seeded on patterns of different geometry, size and surface coatings and their migration
characteristics are monitored. Durotaxis [40]: Cells are seeded on a substrate of variable
stiffness and respond by changing traction forces, cell spread area and migration direction.
Wound healing [26]: A “wound” is formed on a confluent tumor monolayer, and the wound
closure dynamics are monitored. 3D ECM [39]: Cells are seeded inside the 3D ECM and
migrate depending on the ECM architecture (stiffness, pore size and ligand concentration);
ECM fibers are outlined with black curved lines. Microfluidics [28, 32, 147, 206]: Cytokine
gradients can be established in a 3D matrix by flowing different chemokine concentration
(CHIGH - CLOW) solutions in the left and right microchannels; Interstitial flow can be
established by adjusting the hydrostatic pressure (PHIGH - PLOW) in the left and right
microchannels; streamlines are indicated with dark magenta lines. Micropipette, Boyden
chamber and microfluidics assays enable control of biochemical gradients. Durotaxis, 3D
ECM and microfluidics assays enable control of biophysical forces (ECM stiffness and
interstitial flow). Wound healing and micropatterning assay enable control of intercellular
distances, whereas only micropatterning assays enable control of substrate topography.
Growth-factor gradients are indicated by the purple triangles. ECM stiffness gradients are
indicated by the dark brown triangle. Blue arrows indicate direction of tumor cell migration.
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Computational methods provide insight into tumor progression. A) Cell signaling models
capture the dynamics of protein activation and are useful in identifying key signaling
molecules and events, such as the role of EGFR concentration on ERK-1/2 phosphorylation.
Colored lines represent different concentrations of EGF (red, blue, and green are 50 ng/ml,
0.5 ng/ml, and 0.125 ng/ml EGF, respectively). Symbols in panel 3 represent experimental
data, demonstrating that the model well-captures the dynamics of EGF-induced ERK-1/2
phosphorylation (adapted from [64]) B) The subcellular element model recapitulates cell-
level phenomena by discretizing the cell into a series of nodes and defining mechanical
potentials that govern the interaction of the nodes. The panels demonstrate elongation of a
cell under 1 nN of tensile force; the filaments indicate interactions between nodes, which lie
at the intersection of the filaments (adapted from [63]) C) A multi-scale agent-based model
captures the dynamics of tumor intravasation. The subset of models that contributed to the
overall multi-scale model was comprised of a simplified set of differential equations for
intracellular adhesion signaling, a modified Hertz model for intercellular adhesion
mechanics, and the Langevin equation for multi-cellular interactions. The panels
demonstrate a tumor cell (red) approaching the endothelium (green), forming nascent N-
cadherin bonds (yellow), disrupting endothelial cell VE-cadherin bonds, and traversing the
endothelium (adapted from [66]) D) An off-lattice hybrid discrete-continuum approach
modeled the growth of a whole tumor and invasion at the tumor periphery. The model was
comprised of a continuum model for nutrient transport, and a discrete model for single cell
behavior such as motility, adhesion, and proliferation. The model demonstrated that single
cell adhesion plays a role in determining the fate and morphology of the tumor mass
(adapted from [59]).
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Chemical factors influence the cellular response to mechanical factors and vice versa. MMP
and matrix secretion modulates the stiffness and pore size of the surrounding matrix, while
GFR activation influences integrin expression and activation. MMP-mediated matrix
degradation releases chemical signals, while integrin activation and clustering can alter GFR
expression and activation. GFRs and integrins can form macromolecular complexes, and
elements of the intracellular signaling pathway are shared. Interstitial flow induces
mechanical signals through fluid shear and pressure stresses, while simultaneously inducing
chemical signals through convection of autocrine and paracrine signaling factors.
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Table 2
Approximate values for parameters governing tumor cell migration.
Parameter Value Notes Source
Stiffness
Normal stromal ECM stiffness 200 Pa Unconfined compression with electromechanical
indenter
[12]
Mammary adenocarcinoma ECM stiffness 4×103 Pa Explants of tumor tissue from MMTV-Her2/neu, Myc,
and Ras transgenic mice measured by unconfined
compression
[12]
Colon adenocarcinoma stiffness 4×103 Pa Explants of tumor tissue from L5147T mouse
xenografts measured by confined compression
[207]
Glioblastoma stiffness 26×103 Pa Explants of tumor tissue from U87 mouse xenografts




175 Pa Unconfined compression with electromechanical
indenter
[12]
Tissue culture plastic 109 Pa Elastic modulus [208]
Collagen gel elastic modulus 8 Pa 0.5 mg/ml collagen density, storage modulus measured
by parallel plate rheology
[108]
328 Pa 2 mg/ml measured with electromechanical indenter [12]
Collagen fiber extensional modulus 9×109 Pa Force applied to fiber, strain measured by x-ray
crystallography
[109]
Cell Stiffness 1×100 – 1×103 Pa Highly dependent on cell type, culture substrate
stiffness, and mechanical testing method. Lower
stiffnesses measured by particle tracking
microrheology for cells embedded within collagen gel
[96]. Higher stiffnesses measured by AFM on




Basement membrane pore size in vivo 50–100 nm Measured by electron microscopy [210]
Tumor-associated matrix pore size 20–130 nm Measured by electron microscopy of human melanoma
implanted subcutaneously. Two distinct regions of
matrix were observed. Bundles of aligned collagen
fibrils with interfibrillar distances of 20–42 nm and
bundles of poorly organized fibrils with interfibrillar
distances of 75–130 nm.
[211]
<150 nm Herpes simplex virus (HSV, ~150 nm in diameter) did
not penetrate into collagen-rich areas of human
melanoma implanted into mouse skinfold chambers.
Treatment with collagenase increased transport of HSV
into the tumor.
[212]
Collagen gel pore size 2×103 nm 4.0 mg/ml collagen gel polymerized at 37°C [110]
11×103 nm 1.0 mg/ml collagen gel polymerized at 22°C [110]
Tumor cell dimensions 3D 50×103 nm Major axis length of MDA-MB-231 in fibroblast
derived ECM, measured from image provided by
reference
[213]
Mesenchymal migrating cell microtrack 10–15×103 nm Diameter of defect in ECM generated by
proteolytically active migration
[4]
Collagen fiber bundle diameter 2–10×103 nm Measured in vivo [214]
Collagen fibril diameter 35 nm Collagen type I gel polymerized at pH7 measured by
emission scanning electron microscope
[215]
75 nm Measured by electron micrograph from in vivo tissue
samples
[214]
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Parameter Value Notes Source
Transport Properties
Chemokine and growth factor diffusivity 130–160×10−8 cm2/s CCL5, CCL17, CCL21 in dilute solution [117]
10×10−7 cm2/s EGF in dilute agarose gel [216]
Oxygen diffusivity 5×10−5 cm2/s In cell culture medium [217]
Collagen gel permeability 10−13 m2 Measured in a 2 mg/ml collagen gel in a microfluidic
device with a modified PIV technique
[32]
10−13–10−14 m2 2.5 mg/ml [171]
Colon adenocarcinoma permeability 3.4×10−16 m2 Explants of tumor tissue from L5147T mouse
xenografts measured by confined compression and
assuming a poroelastic model for deformation
[207]
Glioblastoma permeability 4.8×10−16 m2 Explants of tumor tissue from U87 mouse xenografts
measured by confined compression and assuming a
poroelastic model for deformation
[207]
Interstitial flow speed 0.1–4.0×10−6 m/s Measured in vivo by FRAP [167], [168]
Computational model for IF in solid tumors < 20×10−6 m/s The magnitude of IF speed depends on ratio of
transvascular to interstitial flow resistance. Larger
resistance to flow in the interstitium creates high IF
speed at the tumor periphery.
[57, 166]
Forces
Myosin II motor force 1.4–3.5 pN Measured using an optical trap [218], [219]
Force generated by actin polymerization 5 pN/filament Dependent on experimental method and platform [13]
α5β1/fibronectin bond strength 0.1–100 pN Dependent on loading rate and method. Lower
strengths measured with magnetic tweezers, higher
strengths measured with AFM
[13]
Cellular contractile force 5×103 pN Epithelial cell edge measured on fibronectin coated
pillars
[220]
300×103 pN MDA-MB-231 total magnitude of contractile force
measured on compliant substrate
[221]
2×106 pN Fibroblast whole cell on collagen coated compliant
substrate
[222]
Intratumoral IFP 4–38 mmHg Mean IFP measured for various tumors measured in
vivo. Brain tumors are characterized by the lowest IFP
with a mean of 4.6 mmHg, and renal cell carcinomas
are characterized by the highest IFP with a mean of 38
mmHg. Individual mammary carcinomas varied from
4.0–53.0 mmHg, with a mean of 23.7 mmHg. IFP is a
function tumor size and of position within the tumor.
[223], [166]
Normal IFP 0–0.4 mmHg Control measurement within rat thigh muscle. [223]
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